Beta-adrenoceptor antagonists in psychiatry and neurology.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001007:Anxiety / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy; D002490:Central Nervous System / Q000378:metabolism; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008881:Migraine Disorders / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta